PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of General Surgery of Ruijin Hospital, Shanghai Institute of Digestive Surgery, and Shanghai Key Laboratory for Gastric Neoplasms, Shanghai Jiao Tong University School of Medicine, 200025, Shanghai, China.\', \'Department of Critical Care Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, 200025, Shanghai, China.\', \'Department of Infection Control, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, 200025, Shanghai, China.\', \'Department of Pulmonary and Critical Care Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, 200025, Shanghai, China.\', \'Department of Endocrinology and Metabolism Disease, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, 200025, Shanghai, China.\', \'Emergency Department, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, 200025, Shanghai, China.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.7150/ijbs.47652
?:hasPublicationType
?:journal
  • International journal of biological sciences
is ?:pmid of
?:pmid
?:pmid
  • 32760206
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.686
?:rankingScore_hIndex
  • 64
is ?:relation_isRelatedTo_publication of
?:title
  • Glucocorticoids improve severe or critical COVID-19 by activating ACE2 and reducing IL-6 levels.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all